急性脑梗死患者血清HMGB1、OPG和MIF水平的变化及PAS三联疗法的干预作用

被引:11
作者
凌芳
李强
聂德云
机构
[1] 武汉市第五医院神经内科
关键词
脑梗死; 高迁移率族蛋白B1; 骨保护素; 巨噬细胞移动抑制因子; 动脉粥样硬化; 阿托伐他汀; 普罗布考;
D O I
暂无
中图分类号
R743.33 [脑栓塞];
学科分类号
摘要
目的探讨急性脑梗死患者血清高迁移率族蛋白B1(HMGB1)、骨保护素(OPG)及巨噬细胞移动抑制因子(MIF)水平的变化以及普罗布考、阿司匹林、他汀类药物(PAS)三联疗法对其干预作用。方法选择150例急性脑梗死患者,根据颈动脉超声检查结果分为颈动脉稳定斑块组(50例)和颈动脉易损斑块组(100例)。将稳定斑块组作为对照组,易损斑块组抽血检查后按随机数字法分为AS组50例(阿司匹林100mg/d,阿托伐他汀20mg/d,口服)和PAS组50例(阿司匹林100mg/d,阿托伐他汀20mg/d,普罗布考0.25/次,2次/d,口服)。比较治疗前和治疗后4周血清HMGB1、OPG和MIF水平。结果治疗前,易损斑块组中两亚组血清HMGB1、OPG和MIF含量均明显高于稳定斑块组,差异有显著统计学意义(均P<0.01);两亚组中血清HMGB1、OPG和MIF含量差异无统计学意义(均P>0.05)。治疗后4周,PAS组中血清HMGB1,OPG和MIF含量均明显低于AS组,且各指标下降幅度均高于AS组,差异有显著统计学意义(均P<0.01)。结论血清HMGB1、OPG和MIF均参与脑梗死患者动脉粥样硬化的进程,可作为评估颈动脉粥样硬化斑块不稳定性的预测因子,PAS三联疗法可有效降低其血清浓度,具有更强的抗炎作用,可提高易损斑块的稳定性。
引用
收藏
页码:87 / 91
页数:5
相关论文
共 6 条
[2]  
High-Mobility Group Box Protein 1 Neutralization Reduces Development of Diet-Induced Atherosclerosis in Apolipoprotein E–Deficient Mice[J] . Peter Kanellakis,Alex Agrotis,Tin Soe Kyaw,Christine Koulis,Ingo Ahrens,Shuji Mori,Hideo K. Takahashi,Keyue Liu,Karlheinz Peter,Masahiro Nishibori,Alex Bobik.Arteriosclerosis, Thrombosis, and Vascular Biology . 2011 (2)
[3]  
Increased serum HMGB1 is related to the severity of coronary artery stenosis[J] . Xiaorong Hu,Hong Jiang,Qijun Bai,Xiaoya Zhou,Changwu Xu,Zhibing Lu,Bo Cui,Huazhi Wen.Clinica Chimica Acta . 2009 (1)
[4]  
Osteoprotegerin and B-type natriuretic peptide in non-ST elevation acute coronary syndromes: Relation to coronary artery narrowing and plaques number[J] . Alberto Palazzuoli,Vittoria Rizzello,Anna Calabrò,Maddalena Gallotta,Giuseppe Martini,Ilaria Quatrini,Maria Stella Campagna,Beatrice Franci,Ranuccio Nuti.Clinica Chimica Acta . 2008 (1)
[5]   Relation of osteoprotegerin to coronary calcium and aortic plaque (from The Dallas Heart Study) [J].
Abedin, Moeen ;
Omland, Torbjorn ;
Ueland, Thor ;
Khera, Amit ;
Aukrust, Pal ;
Murphy, Sabina A. ;
Jain, Tulika ;
Gruntmanis, Ugis ;
McGuire, Darren K. ;
de Lemos, James A. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (04) :513-518
[6]  
Anti-inflammatory and im-mune modulation therapy against atherosclerosis .2 Yamashita T,Hirata K. Nippon Rinsho . 2011